American IRA Discusses How to Think About Self-Directed SIMPLE-IRAs American IRA Discusses How to Think About Self-Directed SIMPLE-IRAs
CHARLOTTE, NC / ACCESSWIRE / April 10, 2021 / For some retirement investors, simply thinking…
Petroteq Announces Equity Raise, Debenture Amendment and Debt Conversions
SHERMAN OAKS, CA / ACCESSWIRE / April 9, 2021 / Petroteq Energy Inc. (“Petroteq” or…
Valneva Announces Publication of 2020 Universal Registration Document and Provides Business Updates
Saint-Herblain (France), April 10, 2021 – Valneva SE (“Valneva” or the “Company”), a specialty vaccine…
Valneva Files Registration Statement for Proposed United States Initial Public Offering
Saint-Herblain (France), April 10, 2021 – Valneva SE (the “Company”), a specialty vaccine company focused…
Biogen Announces Two New Nominees for Election to Board of Directors
Nominees bring diverse business and public health experience key to Biogen’s mission to pioneer and…
Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
Company Announcement FDA action date is Oct 10, 2021 BLA submission supported by positive pivotal…
Scilex Holding, a Subsidiary of Sorrento, Has Received From FDA a sNDA Approval for ZTlido® Label Expansion
PALO ALTO, Calif., April 09, 2021 (GLOBE NEWSWIRE) — Scilex Holding (“Scilex”), an over 99%…
Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and…
Why COVID is just the tip of a terrifying, but potentially revolutionary, antibiotic resistant iceberg
LONDON, April 09, 2021 (GLOBE NEWSWIRE) — Based in the UK, SpectrumX is currently raising…
Fulcrum Therapeutics Presents Published Structure of Investigational Small Molecule FTX-6058 at the American Chemical Society (ACS) Spring 2021 Virtual Conference
Company initiates dosing in Phase 1 healthy volunteer multiple ascending dose (MAD) cohort CAMBRIDGE, Mass., April…